JXTGE to sell Irvine Scientific to FujiFilm3 Apr 2018
With the acquisition of Irvine Scientific, FujiFilm will have a full product line supporting customers supplying antibody drugs to assisted reproductive technologies and cell therapy.
JXTG Nippon Oil & Energy Corporation has agreed to sell Irvine Scientific Sales Company and IS Japan Co. to FUJIFILM Corporation (FujiFilm).
JXTG Energy acquired Irvine Scientific in 1987 and launched IS Japan in 1989; both companies have continuously expanded to become significant suppliers of cell culture media and products to the biopharmaceutical, cell therapy and medical markets in their respective regions. Although the business has experienced significant growth, life sciences and medical devices are not synergistic for JXTG Energy’s core business going forward.
JXTG Energy determined it would be best for the Irvine Scientific group to continue under ownership which is synergistic to Irvine Scientific products and services.
FujiFilm announced it would acquire the Irvine Scientific group and maximize their synergy in its significant and growing bio-medical businesses. FujiFilm expects increased demand and needs of biopharmaceutical products and regenerative medicine therapy is driving current rapid growth of the cell culture media market and estimates continued strong growth in the coming years.
Irvine Scientific is an innovator of cell culture media, to biopharmaceutical, assisted reproductive technology, and regenerative medicine customers. By applying its high capabilities in R&D and quality systems, coupled with long experience, Irvine Scientific has developed a strong presence serving customer needs. Irvine Scientific’s California, USA and Saitama, Japan cGMP facilities will be transferred and provide capacity to supply high-quality products in a timely manner worldwide.
FujiFilm is advancing growth strategies within healthcare space, investing in biopharmaceutical contract development/manufacturing, and regenerative medicine. Prior to this announcement, FujiFilm acquired the global leader in iPS cell technologies, Cellular Dynamics International (CDI) and has entered into cell culture media space with the acquisition of general reagents manufacturer, Wako Pure Chemical Industries (Wako Pure Chemical). With the acquisition of Irvine Scientific, FujiFilm will have a full product line supporting customers supplying antibody drugs to assisted reproductive technologies and cell therapy, and will also enable FujiFilm to strengthen its overseas business. FujiFilm announced it plans to further accelerate competitive media development and expand cell culture media business by applying chemical synthesis and design technologies acquired through its original business in photographic films and from Japan Tissue Engineering (“J-TEC”), as well as cell growth and manufacturing technologies from CDI and FUJIFILM Diosynth Biotechnologies.
In addition, FujiFilm plans on maximizing synergies outside of cell culture business, combining media technologies and products of Irvine Scientific with FujiFilm Group’s biomedical technologies and products. Specific synergies mentioned include (1) expansion of contract development/manufacturing of biomedicine (2) acceleration of R&D in regenerative medicine (3) expansion of research-purpose chemical reagents business.
The Irvine Scientific Group is excited about this change and anticipates continued acceleration of its cell culture media businesses under new ownership.
TraceLink unveils Product Information Manager for its digital information sharing platform
12 Jul 2018
Product Information Manager addresses a broad range of use cases, beginning with saleable returns.Read more
Stability studies trends
10 Jul 2018
Dr Ramesh Jagadeesan, Sr. Director - Analytical Development at Recipharm, speaks to CPhI Online on the trends and challenges involved with conducting stability studies for firms that supply to multiple countries, and the advantages of using a contracto...Read more
Recipharm launches standalone serialisation service
5 Jul 2018
Company will be able to add 2D codes, human-readable text and tamper evidence to pre-packed medicines using existing equipment across its facilities.Read more
CPhI Worldwide opens entries for 15th Annual Pharma Awards
5 Jul 2018
Winners will be announced live at the Gala Ceremony in Madrid with over 500 of Pharma’s top executives.Read more
Catalent to acquire Juniper Pharmaceuticals
5 Jul 2018
$133 million deal adds European Early Development Center of Excellence to global network.Read more
Insights in lyophilization science
4 Jul 2018
The latest developments in process development, nucleation control, scale-up of freeze drying cycles and development in lyophilization technology.Read more
Bosch to sell its packaging business
4 Jul 2018
Packaging technology is not a core Bosch business.Read more
Plasticell leads gene therapy manufacturing consortium
3 Jul 2018
Consortium to develop advanced technologies for the manufacturing of ex vivo gene therapies.Read more
Forté Pharma strengthens its leadership in weight control in France
1 Jul 2018
Company consolidated as one of the leading laboratories in weight control thanks to the development of its existing range and new launches.Read more
I Holland woos exhibition visitors with new tabletting technologies
28 Jun 2018
Company's Wear Indicator Layer attracts the most attention.Read more
Are you a supplier
Here's what we can do for you
- Generate quality leads for your business
- Stay visible for 365 days of the year
- Receive product inquiries and respond to meeting requests directly
- Improve company online presence through Search Engine Optimisation